Efficacy and safety of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension and valvular heart disease Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by